1'752 companies found
Devatis AG
Cham · Since 2014
The core activity of Devatis AG is the manufacture and distribution of high-quality pharmaceutical finished products and active ingredients, particularly generics, in various therapeutic areas such as hematology, oncology, ophthalmology and respiratory system.
Develco Pharma Schweiz AG
Birsfelden · Since 2006
The core activity of Develco Pharma Schweiz AG is the development and production of innovative formulations of medicines with known active ingredients, particularly with extended or modified releases, as well as contract manufacturing and life cycle management of pharmaceuticals. The focus is on the treatment of severe pain and ADHD.
DigeHealth SA
Epalinges · Since 2023
DigeHealth SA develops wearable devices and software for continuous gut monitoring by recording bowel sounds and physiological metrics such as heart rate and activity. The company combines these data with AI-powered bowel sound recognition to provide real-world data for researchers and users; its products are not medical devices and are intended for research and personal use.
DiNAQOR AG
Pfäffikon Sz · Since 2024
DiNAQOR AG is a biotechnology company builder that develops platform technologies and launches focused companies in tissue science, precision medicine and genetic therapies. Its portfolio includes entities such as DiNATEQ, DiNAMIQS, DiNABiOS and DAiNA; the group provides access to GMP‑compliant viral vector manufacturing and advances precision gene‑therapy programs for cardiomyopathies, heart failure and polycystic kidney disease.
DISCH AG
Othmarsingen · Since 1961
DISCH AG is a CDMO for pharmaceuticals and dietary supplements specializing in the development and manufacture of solid dosage forms such as lozenges, toffees and pastilles. The company provides end-to-end services including product concept and development, validation, GMP production, quality control and packaging, and acts as a contract manufacturer for pharmaceutical and food industry clients and retailers.
DISCO Pharmaceuticals Swiss GmbH
Schlieren · Since 2023
DISCO Pharmaceuticals Swiss GmbH applies a surfaceome mapping platform to identify cell-surface proteins and protein communities, providing molecular targets for antibody-based cancer therapies. Its initial discovery programs focus on small cell lung cancer and microsatellite-stable colorectal cancer, supporting candidate generation for mono- and bispecific antibodies and antibody–drug conjugates.
Dispopharm Services GmbH
Basel · Since 1994
The core activity of Dispopharm Services is the provision of pharmaceutical and healthcare services.
Dompé International SA
Aigle · Since 2002
Dompé International SA is a biopharmaceutical company engaged in research, development and manufacturing of medicines. It focuses on ophthalmic, neurological and pain‑related indications, including development of recombinant human nerve growth factor (rhNGF), and employs virtual screening technologies such as the Exscalate platform for drug discovery.
dragonPharm GmbH
Winterthur · Since 2012
The core activity of dragonPharm GmbH is the provision of pharmaceutical services, particularly in the areas of prevention, therapy and development. The company is committed to providing easy access to healthcare, disseminating knowledge and ensuring a sustainable pharmaceutical and medical basic care.
Dr. Andres Pharma AG
Zurich · Since 2015
The core activity of Dr. Andres Pharma AG is the development and manufacture of natural products based on biologically cultivated medicinal plants, particularly for the treatment of rheumatic complaints and accident and sports injuries.
Dr. Falk Pharma AG
Glattbrugg · Since 2020
Dr. Falk Pharma AG is a company in digestive and metabolic medicine that develops and distributes pharmaceuticals for gastroenterology and hepatology. Its activities include marketing prescription medicines (e.g. Salofalk, Budenofalk, Ursofalk, Jorveza, Azafalk), supporting medical projects, and providing educational and patient information resources.
Dr. Heinz Welti AG, Fabrikation chemisch-pharmazeutischer Produkte
Gebenstorf · Since 1945
The core activity of Dr. Heinz Welti AG is the manufacture of pharmaceuticals in various forms (liquid, semi-solid, solid) for the Swiss and international healthcare market. This includes both the development and production of its own products as well as contract manufacturing of pharmaceuticals for other companies.
Dr. Krayenbühl GmbH
Pfaffhausen · Since 2014
Dr. Krayenbühl GmbH provides scientific information on iron deficiency and sells the dietary supplement “Eisen low dose” via its online shop; one tablet contains 6 mg iron (II) sulfate. The website includes product details, usage instructions, study references and an online ordering option for Switzerland and Liechtenstein.
Dr. Pharmandrus GmbH
Eich · Since 2016
The core activity of Dr. Pharmandrus GmbH is the development, manufacture and marketing of dietary supplements, in particular vitamin C products such as VitaScorbin drops, as well as the distribution of over-the-counter pharmaceutical products on the Swiss market.
Dr. Reddy's Laboratories SA
Basel · Since 2007
The company's core activity is the development, manufacture and marketing of pharmaceutical products, including generics, biosimilars, over-the-counter products and innovative medicines for various therapeutic areas such as gastroenterology, cardiology, diabetology, oncology, pain management and dermatology.
Dr. Schweizer Immunocare AG
Neuhausen Am Rheinfall · Since 2015
The core activity of Dr. Schweizer Immunocare AG is the development, manufacture and distribution of dietary supplements, particularly in the area of immune system support.
Drug'On Pharma Switzerland AG
Liestal · Since 2009
Drug'On Pharma Switzerland AG is part of the Orofino Pharmaceuticals group and operates a chemical production site manufacturing active pharmaceutical ingredients (APIs) and intermediates. The site comprises four production buildings and provides chemical manufacturing capabilities for APIs and intermediates.
DSM Nutritional Products Holding AG
Kaiseraugst · Since 2004
DXC I. C. AG
Hünenberg · Since 2016
The core activity of DXC I.C. AG includes: International Trading, Product development and production, Project investments in biotechnology, Marketing development for health, wellness and medical products. The company focuses particularly on the development and production of health products based on the combination of natural ingredients and innovative technologies.
DXC RT AG
Aesch Bl · Since 2015
The core activity of DXC RT AG is the development and application of biotechnological solutions, particularly the NovaPhyRT technology, for the cultivation of plant roots in laboratories. The company specializes in the production of root biomass, including Hairy Root, Adventitious Root and Callus and cell suspensions, and supplies these products to customers in the cosmetics and care industry. In addition, DXC RT also offers customized research and development services.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register